Morning Overview on MSN
An experimental weight-loss pill just matched the blockbuster injections in a trial — letting patients skip the needle and take a daily tablet instead
For the millions of Americans injecting themselves weekly with Wegovy, Ozempic, Mounjaro, or Zepbound, the promise of a ...
Our collective appetite for weight loss drugs has become pretty much insatiable over the past few years. It’s thought that around 1.5 million people in the UK are on GLP-1 agonist medications to curb ...
People with type 2 diabetes who are taking a GLP-1 now have a newly branded option for treatment. Novo Nordisk, which makes the GLP-1 semaglutide medications Ozempic and Wegovy, announced that it’s ...
After receiving FDA approval in December 2025, Danish pharmaceutical company Novo Nordisk is rolling out a pill version of their popular Wegovy weight loss drug in January 2026. Senior Correspondent ...
The tablet - orforglipron - is available in the US and could soon launch in the UK.
The recommendation paves the way for it to become the first tablet approved to treat obesity in the European Union.
Data shows orforglipron could in future avoid need to take other long-term medications for diseases associated with obesity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results